Cargando…
FGFR regulator Memo1 is dispensable for FGF23 expression by osteoblasts during folic acid‐driven kidney injury
Loss of the mediator Of cell motility 1 (Memo1) in mice caused kidney disease and a bone disease with diminished osteoblast and osteoclast biomarkers in serum, resembling alterations occurring in adynamic bone disease in humans with chronic kidney disease or in Klotho‐deficient mice. Here, we invest...
Autores principales: | Bartos, Katalin, Moor, Matthias B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040316/ https://www.ncbi.nlm.nih.gov/pubmed/36967231 http://dx.doi.org/10.14814/phy2.15650 |
Ejemplares similares
-
Renal FGF23 signaling depends on redox protein Memo1 and promotes orthovanadate-sensitive protein phosphotyrosyl phosphatase activity
por: Bartos, Katalin, et al.
Publicado: (2022) -
Mutant hFGF23(A12D) stimulates osteoblast differentiation through FGFR3
por: Tu, Yilin, et al.
Publicado: (2019) -
Memo1 gene expression in kidney and bone is unaffected by dietary mineral load and calciotropic hormones
por: Moor, Matthias B., et al.
Publicado: (2020) -
FGF23 protects osteoblasts from dexamethasone-induced oxidative injury
por: Ji, Feng, et al.
Publicado: (2020) -
Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23
por: Xiao, Zhousheng, et al.
Publicado: (2014)